Skip to main content

Table 2 Factors related to presence of cervical lesions

From: Co-infection of sexually transmitted pathogens and Human Papillomavirus in cervical samples of women of Brazil

Variables

Without cervix lesions

With cervix lesions

OR (Crude)

OR (Adjusted)b

n = 70 (%)

n = 62 (%)

P (Wald’s test)

OR

IC 95%

P (Wald’s test)

OR

IC 95%

 

n (%)

n (%)

      

Demographic and sexual profile

 Age

  ≤ 31 years

28 (40.0)

16 (25.8)

0.161

1

  

1

 

  32–42 years

19 (27.1)

25 (40.3)

0.057

2.30

0.98–5.42

0.316

2.27

0.46–11.18

  43 years or more

23 (32.9)

21 (33.9)

0.281

1.60

0.68–3.75

0.470

0.57

0.12–2.64

 Residence

  Urban area

60 (85.7)

41 (66.1)

 

1

    

  Countryside

10 (14.3)

21 (33.9)

0.010

3.07

1.31–7.20

   

 Education level

  At least primary school completed

39 (55.7)

18 (29.0)

 

1

    

  Less than primary school

31 (44.3)

44 (71.0)

0.002

3.08

1.49–6.34

   

 In a stable relationship

  No

57 (81.4)

16 (25.8)

 

1

  

1

 

  Yes

13 (18.6)

46 (74.2)

<0.0001

12.01

5.51–28.87

< 0.001

14.21

3.67–55.02

 N° of sexual partners in all life

  1

30 (42.9)

16 (25.8)

0.121

1

    

  2–5

34 (48.6)

38 (61.3)

0.057

2.10

0.98–4.50

   

  > 5

6 (8.6)

8 (12.9)

0.141

2.50

0.738–8.47

   

 Ethnic group declared

  White

17 (24.3)

13 (21.0)

 

1

    

  No white

53 (75.7)

49 (79.0)

0.650

1.21

0.53–2.75

   

 Condom use

  Always

12 (17.6)a

11 (17.7)

0.988

1

    

  Sometimes

15 (22.1)a

13 (21.0)

0.921

0.92

0.31–2.85

   

  Never/rarely

41 (60.3)a

38 (61.3)

0.981

1.01

0.40–2.56

   

 Contraceptive pills/hormone injection use

  No

44 (62.9)

43 (69.4)

 

1

    

  Yes

26 (37.1)

19 (30.6)

0.432

0.75

0.36–1.55

   

 Pregnancy

  0

6 (8.6)

3 (4.8)

0.425

1

    

  1–2

34 (48.6)

26 (41.9)

0.573

1.53

0.35–6.70

   

  ≥ 3

30 (42.9)

33 (53.2)

0.294

2.20

0.51–9.58

   

 Abortion

  No

42 (60.0)

43 (69.4)

 

1

    

  Yes

28 (40.0)

19 (30.6)

0.264

0.66

0.32–1.36

   

STA detection

 HPV

  Negative

52 (74.3)

9 (14.5)

 

1

 

< 0.001

1

 

  Positive

18 (25.7)

53 (85.5)

<0.001

17.01

7.01–41.23

16.81

4.19–67.42

Mollicutes

  Negative

22 (31.4)

5 (8.1)

 

1

    

  Positive

48 (68.6)

57 (91.9)

0.002

5.23

1.84–14.85

 

U. parvum (qPCR)

  Negative

29 (41.4)

13 (21.0)

 

1

  

1

0.36–5.98

  Positive

41 (58.6)

49 (79.0)

0.013

2.66

1.23–5.79

0.593

1.47

 

U. parvum (PCR)

  Negative

35 (50.0)

30 (48.4)

 

1

    

  Positive

35 (50.0)

32 (51.6)

0.853

1.07

0.54–2.11

   

U. parvum serotype 1

  Negative

61 (87.1)

61 (98.4)

 

1

    

  Positive

9 (12.9)

1 (1.6)

0.040

0.11

0.01–0.90

   

U. parvum serotypes 3/14

  Negative

60 (85.7)

51 (82.3)

 

1

    

  Positive

10 (14.3)

11 (17.7)

0.589

1.29

0.51–3.29

   

U. parvum serotype 6

  Negative

53 (75.7)

61 (98.4)

 

1

    

  Positive

17 (24.3)

1 (1.6)

0.004

0.05

0.007–0.40

   

U. urealyticum (qPCR)

  Negative

61 (87.1)

54 (87.1)

 

1

    

  Positive

9 (12.9)

8 (12.9)

0.994

1.00

0.36–2.79

   

U. urealyticum (PCR)

  Negative

67 (95.7)

57 (91.9)

 

1

    

  Positive

3 (4.3)

5 (8.1)

0.371

1.96

0.45–8.56

   

T. vaginalis

  Negative

66 (94.3)

24 (38.7)

 

1

 

0.003

1

2.04–35.94

  Positive

4 (5.7)

38 (61.3)

<0.001

26.13

8.43–80.98

 

8.566

 

G. vaginalis

  Negative

33 (47.1)

5 (8.1)

 

1

 

0.011

1

1.53–24.61

  Positive

37 (52.9)

57 (91.9)

<0.001

10.17

3.64–28.41

 

6.13

 

C. trachomatis

  Negative

69 (98.6)

60 (96.8)

 

1

    

  Positive

1 (1.4)

2 (3.2)

0.501

2.30

0.20–26.00

   

N. gonorrhoeae

  Negative

55 (78.6)

62 (100.0)

 

1

    

  Positive

15 (21.4)

0 (0)

0.998

0

    
  1. atwo women did not declare using condoms
  2. badjusted for age and positivity in qPCR for U. parvum. The goodness of the adjustment was evaluated by Hosmer-Lemershow test (p = 0.568)